Friday, 22 January 2021

FDA approves Cabenuva as long acting regimen of HIV treatment

FDA approves Cabenuva as long acting regimen of HIV treatment admin Fri, 01/22/2021 - 12:24

source https://www.pharmatutor.org/pharma-news/2021/fda-approves-cabenuva-as-long-acting-regimen-of-hiv-treatment
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Pharma openings

  Opportunity for M.Pharm, Msc or PhD as Scientist at PGIMER M.Pharmacy or M.Sc 6 Year of Research Experience or PhD with 3 year of Experien...